Comparison the efficacy of Attentalin and Atomoxetin in ADHD
Phase 3
- Conditions
- Attention deficit and hyperactivity disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20230419057960N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Patients who recieved Attentin Deficite and Hyoeractivity Disorder due to DSM 5 criteria .
Obtaining Informed consent from parents
Age 6 to 12 years old
Exclusion Criteria
Seizures
Glaucoma
History of hyperthyroidism
Eating disorders (anorexia)
Children with a history of liver , kidney , heart diseases or other chronic illnesses requiring care
Children who have taken MAOI medication for the 15 days prior to entering the study.
substance abuse disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of hyperactivity/attention deficit. Timepoint: before the trial and 3 and 6 weeks later. Method of measurement: ADHD Rating Scale.
- Secondary Outcome Measures
Name Time Method